Table 1.
Schedule of activities
| Follow-up visits | ||||||||
| PROTOCOL ACTIVITIES | Screening Visit | Initial Visit | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Final Visit |
| SCHEDULE OF VISITS | 0 | 15 ± 5 | 30 ± 5 | 45 ± 5 | 60 ± 5 | 75 ± 5 | 90 ± 5 | |
| Clinical History | X | X | X | X | X | X | X | X |
| Physical Examination | X | X | X | X | X | X | X | X |
| Inclusion/Exclusion criteria | X | |||||||
| Informed Consent | X | |||||||
| Clinical assessment of vascular compromise | X | X | X | X | X | X | X | X |
| Clinical assessment of neuropathic compromise | X | X | ||||||
| Laboratory tests | X | X | ||||||
| Ankle/arm index | X | |||||||
| Randomization | X | |||||||
| Treatment administration | X | X | X | X | X | X | ||
| Clinical assessment of the lesion | X | X | X | X | X | X | X | X |
| Measurement of ulcers | X | X | X | X | X | X | X | X |
| Photographic registration | X | X | X | X | X | X | X | |
| Education of patients | X | X | X | X | X | X | X | X |
| Documentation of adverse events | X | X | X | X | X | X | X | X |
| Recording of concomitant medications | X | X | X | X | X | X | X | X |